MedTrace Logo

Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis

NCT00230867 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1800

Last updated 2006-07-04

No results posted yet for this study

Summary

Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the site where the herpes virus is replicating. Iontophoresis uses electric current to enhance the delivery of drugs through the skin. This trial is testing a new iontophoretic device for the delivery of acyclovir cream to treat cold sores.

Conditions

  • Herpes Labialis

Interventions

DEVICE

iontophoretic acyclovir

Sponsors & Collaborators

  • Transport Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Christopher M Hull, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00230867 on ClinicalTrials.gov